Comparison of analysis methodologies for net outcome with edoxaban vs warfarin in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial
Event:
ESC Congress 2018
Topic:
Biostatistics
Session:
Atrial fibrillation, stroke and cardiovascular risk
